Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Liraglutide for Sale > LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - large image1
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - image1
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - image2
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - image3
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - image4
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - image5
LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research buy - image6

LL37 Freeze Dried Peptide Powder Packed in Standard Vial for Lab Research

24 Inquiries

Unit Price:

$68/UNIT EXW

Get Latest Price
CAS No.:

204656-20-2

Grade:

Research Grade

Content:

99%

Port:

qingdao

Brand:

Peptide

Packaging:

5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg

Price valid (until):

2027-01-24

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cosmetics

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Company Profile

    Our company specializes in the research, development, production, and supply of research-grade synthetic peptides and has earned a strong reputation in the field of life science research materials.

    We have an experienced product and sales team that can provide tailored products and customized solutions based on our customers’ experimental needs. Our business spans multiple countries and regions both domestically and internationally, and we have established a stable supply and sales network.

    Adhering to a service philosophy of integrity and quality first, we continuously monitor changes in the research market and promptly adjust our supply plans accordingly. Relying on a well-established customer engagement process, we ensure that orders are executed efficiently and accurately throughout the entire process—from initial inquiry and production scheduling to shipment and delivery.


    Product Description


    This product is a research-grade lyophilized peptide powder prepared through a synthetic process. Each batch undergoes quality control testing and achieves a purity of up to 99%.

    Available in a variety of experimental sizes: 1 mg, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, and 500 mg, packaged in vials.

    Packaging Specifications: Glass vials, 10 vials per box.

    Minimum Order Quantity: 1 kit (10 vials)


    ⚠️ Important Notice: This product is intended solely for in vitro research experiments in life science laboratories and must not be used for human, clinical, medical, or food-related purposes.


    Storage Conditions


    Store in a cool, dry, dark, and low-temperature environment;

    Avoid repeated freeze-thaw cycles;

    Minimize prolonged exposure to air;

    Long-term storage after dissolution is not recommended;

    It is recommended to aliquot the product according to experimental needs.



    Service Information


    1. Shipments will be arranged within 1–2 business days after receipt of payment;

    2. A tracking number will be provided upon shipment to facilitate tracking of the shipment’s status;

    3. Custom packaging is available upon request;

    4. We provide end-to-end business support and will respond to inquiries within 24 hours;

    5. We will continuously monitor the shipping status after the goods are dispatched; if customers have any questions after receiving the goods, they may contact our after-sales service at any time;


    Disclaimer


    This product is intended solely for industrial and laboratory scientific research and is not intended for medical, clinical diagnostic, or therapeutic use. The purchaser is responsible for verifying the product’s compliance with applicable usage scenarios.



    Shop Epitalon High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 4 Shop Tirzepatide-peptide best price various peptide High-efficiency Peptides white powder 20mg Wholesale 40mg-Detailed Image 3 Shop Synthetic Lyophilized Urotensin II for In Vitro Research, Steady Batch Readings, Custom Packing-Detailed Image 3 Shop Synthetic Lyophilized Urotensin II for In Vitro Research, Steady Batch Readings, Custom Packing-Detailed Image 4

    ECHEMI Editorial Reference
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
    Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
    ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
    Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of~10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
    Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Research
    Class:

    GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

    Status:

    FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

    Mechanism:

    A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

    EC50 (GLP1R Ec50):

    ~10 nM

    Source:

    DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

    Clinical Development:

    NCT00781922; NCT01272219

    FDA:

    Victoza, Saxenda (approved 2010-01-25)

    References
    ChEMBL:

    CHEMBL1213363

    DrugBank:

    DB06655

    KEGG DRUG:

    D09199

    PubChem:

    PubChem

    Disclaimer:

    Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cosmetics

    Location:

    Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

    Year of Establishment:

    2026

  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    South Korea

    Liraglutide

    1 G Sep 19, 2026
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    1  Jan 21, 2026
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    India

    Liraglutide

    100 G Mar 4, 2024
    United States

    Semaglutide Liraglutide powder

    10 G Feb 20, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.